StockNews.com Initiates Coverage on T2 Biosystems (NASDAQ:TTOO)

Stock analysts at StockNews.com initiated coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a report released on Sunday. The firm set a “sell” rating on the medical equipment provider’s stock.

T2 Biosystems Stock Up 2.7 %

Shares of NASDAQ:TTOO opened at $0.13 on Friday. T2 Biosystems has a fifty-two week low of $0.06 and a fifty-two week high of $6.80. The firm has a 50-day simple moving average of $0.25 and a 200 day simple moving average of $1.12.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.